COMP <GO>
AMN vs EFOR // FREE CASH FLOW YIELD
AMN Healthcare Services Inc (NYSE) VS. Everforth Inc. (NYSE) • 15-METRIC TALLY: AMN 3
— EFOR 7
▲ FREE CASH FLOW YIELD LEADER: EFOR
LAST: $46.94 (+0.47%) • MKT CAP: $1.82B
fcf-yield
12.86%
LAST: $37.01 (-4.47%) • MKT CAP: $1.52B
fcf-yield
18.99%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMN VS. EFOR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMN | EFOR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 28.90% | -0.60 | EFOR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.20% | 6.50% | -13.70 | EFOR | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 12.86% | 18.99% | -6.13 | EFOR | /fcf-yield <GO> |
| Operating Margin | -2.00% | 5.80% | -7.80 | EFOR | /operating-margins <GO> |
| Net Profit Margin | -3.50% | 2.90% | -6.40 | EFOR | /net-margins <GO> |
| Revenue Growth (YoY) | -8.50% | -2.90% | -5.60 | EFOR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.76 | 2.35 | +0.41 | AMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | EFOR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.9 | 52.5 | +23.38 | AMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 12.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $1.52B | $300.6M | AMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMN REV | EFOR REV | AMN GROSS % | EFOR GROSS % | AMN FCF | EFOR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.73B | $3.98B | 28.3% | 28.9% | $233.8M | $288.1M |
| FY 2024 | $2.98B | $4.10B | 30.8% | 28.9% | $239.5M | $364.7M |
| FY 2023 | $3.79B | $4.45B | — | — | $372.2M | $456.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMN // BETA —
EFOR // BETA —